Development and validation of simultaneous identification of 26 mammalian and poultry species by a multiplex assay

Author(s):  
Chikahiro Mori ◽  
Shuichi Matsumura
2020 ◽  
Vol 103 (3) ◽  
pp. 857-864
Author(s):  
Sonal Shah ◽  
Tushar Dhanani ◽  
Sonu Sharma ◽  
Raghuraj Singh ◽  
Satyanshu Kumar ◽  
...  

Abstract Background Ageratum conyzoides is an aromatic plant. It is considered as an invasive and cosmopolite weed, widely spread in tropical and subtropical regions. Phytochemicals such as benzopyrenes, flavonoids, and terpenoids are reported from A. conyzoides. Objective Development and validation of a reversed-phase HPLC-photodiode array (PDA) detection method for simultaneous identification and quantification of coumarin, precocene-I, β-caryophyllene oxide, α-humulene, and β-caryophyllene in extracts of A. conyzoides and essential oils was carried out. Methods Separation of analytes was achieved on a RP-18 (250 mm × 4.6 mm, 5 µm) column using a solvent system comprising of a mixture of acetonitrile and water with 0.05% trifluoroacetic acid in gradient elution mode at ambient temperature with flow rate of 1 mL/min. Results The retention time of coumarin, precocene-I, β-caryophyllene oxide, α-humulene, and β-caryophyllene was 4.38, 12.86, 20.10, 33.34, and 35.11 min, respectively. Limits of detection for coumarin, precocene-I, β-caryophyllene oxide, α-humulene, and β-caryophyllene were 2.5, 2.5, 2.5, 0.025, and 2.5 µg/mL, respectively. Similarly, LOQ were 10, 10, 10, 0.10, and 10 µg/mL for coumarin, precocene-I, β-caryophyllene oxide, α-humulene, and β- caryophyllene, respectively. Repeatabilities (RSD, %) values for intraday and interday precision for coumarin, precocene-I, β-caryophyllene oxide, α-humulene, and β-caryophyllene was 0.765–2.086 and 0.886–2.128; 0.879–1.672 and 0.979–1.825; 0.696–2.418 and 0.768–2.592; 1.728–2.362 and 1.965–2.378; 1.615–2.897 and 1.658–2.906, respectively. Conclusions The separation of five analytes was achieved within 50 min. The developed and validated HPLC-PDA method was successfully applied for identification and quantification of above five analytes in A. conyzoides extracts and essential oils. The method could be used for meeting the characterization criteria of phytoformulations.


2021 ◽  
Author(s):  
Yiling Qu ◽  
RuiYang Tao ◽  
Huan Yu ◽  
Qi Yang ◽  
Ziwei Wang ◽  
...  

BMC Cancer ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Hideaki Bando ◽  
Takayuki Yoshino ◽  
Eiji Shinozaki ◽  
Tomohiro Nishina ◽  
Kentaro Yamazaki ◽  
...  

Author(s):  
R. D. Ostapiv ◽  
V. І. Tkachenko ◽  
М. І. Bereziuk

The aim of the work was to develop and validate a method for the simultaneous identification and quantification of dihydrostreptomycin and benzylpenicillin in injectable suspensions. The method was validated by testing two preparations in the form of injectable suspensions containing benzylpenicillin 108–144 mg/ml and dihydrostreptomycin 180–220 mg/ml. Test samples were dissolved in purified water P, and standard samples: benzylpenicillin - in methanol (up to a concentration of 126 μg/ml), dihydrostreptomycin - in purified water P (up to a concentration of 200 μg/ml). The maximum allowable total uncertainty of the analysis was 1.64%, which is within the recommendations of SFU 2.0. The samples were separated on a Dionex Ultimate 3000 chromatograph equipped with a Luna C18 (2) 250 × 4.6 mm, 5 μm chromatographic column. The mobile phase was a mixture of acetonitrile and a solution of 0.01 M sodium heptanesulfonate with 0.05 M sodium phosphate trisubstituted, acidified with 0.1 M phosphoric acid to pH 6.0, in a volume ratio of 2: 8. Under mentioned conditions, dihydrostreptomycin and benzylpenicillin were completely separated. The established parameters of the chromatographic system did not exceed the limits specified in the FDA recommendations. The calibration curves were linear in the recommended SFU 2.0 range (80–120% of the nominal concentration of the corresponding active substance). The ratio of the amount of standard sample added to the test samples with its subsequent detection in the preparation was 99.35–100.79% for benzylpenicillin and 99.49–100.12% for dihydrostreptomycin, which does not exceed the limits recommended in SFU 2.0. The precision criterion was 0.07 for dihydrostreptomycin and -0.08 for benzylpenicillin, which is within the limits recommended in SFU 2.0. At the same time, the results of the study by different analysts at different times differed by 1.3% for dihydrostreptomycin and 0.98% for benzylpenicillin, which is well within the limits adopted in the recommendations of the FDA and SFU 2.0. Therefore, the method developed and validated by us for the simultaneous determination of dihydrostreptomycin sulfate and benzylpenicillin procaine in injectable suspensions can be considered suitable for routine analysis.


Sign in / Sign up

Export Citation Format

Share Document